Aetna, a CVS Health company (NYSE:CVS), announced on Tuesday that it is introducing a generative AI-powered conversational experience in its digital channels designed to simplify healthcare.
This offering will allow members to quickly and easily navigate their benefits for a personalised experience.
The new capability was initially launched to a limited population in October, with access expanding throughout the rest of 2025 and the first half of 2026.
Aetna members will be able to use their device to verbally interact with the assistant with full voice enablement. The assistant will also be embedded within Aetna's recently announced Care Paths feature, a digital experience to help members navigate certain conditions.
BioInvent secures EMA positive opinion for Orphan Drug Designation of BI-1808 in CTCL
Lupin launches Risperidone long-acting injectable with 180-day CGT exclusivity in US market
BodyLogicMD supports recommendation to remove black box warnings on certain forms of oestrogen
Fondazione Telethon reports positive opinion for Waskyra marketing authorisation in Europe
Maxx Orthopedics Receives FDA 510(k) Clearance for Its Libertas® Bipolar Hip System
CHMP issues positive opinion for DAWNZERA in hereditary angioedema
Merck to acquire Cidara Therapeutics in USD9.2bn deal to expand antiviral portfolio
Ingenus Pharmaceuticals' generic equivalent to Premarin receives US FDA approval
Ascletis Pharma announces ASC36 and ASC35 co-formulation for clinical development
EirGenix signs second global exclusive licensing deal with Sandoz